These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20864426

  • 1. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit.
    Blandthorn J, Forster DA, Love V.
    Women Birth; 2011 Mar; 24(1):32-9. PubMed ID: 20864426
    [Abstract] [Full Text] [Related]

  • 2. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T, Vavrinková B.
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [Abstract] [Full Text] [Related]

  • 3. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E.
    Drug Alcohol Depend; 2013 Jan 01; 127(1-3):200-6. PubMed ID: 22841456
    [Abstract] [Full Text] [Related]

  • 4. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J, Heilig M, Sarman I.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989
    [Abstract] [Full Text] [Related]

  • 5. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases].
    Lejeune C, Aubisson S, Simmat-Durand L, Cneude F, Piquet M, Gourarier L, Groupe d'Etudes Grossesse et addictions.
    Ann Med Interne (Paris); 2001 Nov 01; 152 Suppl 7():21-7. PubMed ID: 11965095
    [Abstract] [Full Text] [Related]

  • 6. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].
    Loustauneau A, Auriacombe M, Daulouede JP, Tignol J.
    Ann Med Interne (Paris); 2002 Nov 01; 153(7 Suppl):2S31-6. PubMed ID: 12518080
    [Abstract] [Full Text] [Related]

  • 7. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E.
    Eur Addict Res; 2009 Nov 01; 15(3):128-34. PubMed ID: 19332991
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.
    O'Connor A, Alto W, Musgrave K, Gibbons D, Llanto L, Holden S, Karnes J.
    J Am Board Fam Med; 2011 Nov 01; 24(2):194-201. PubMed ID: 21383220
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C, Young D, Hepburn M, Mactier H.
    BJOG; 2009 Apr 01; 116(5):665-71. PubMed ID: 19220239
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES.
    Addiction; 2012 Nov 01; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract] [Full Text] [Related]

  • 14. Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: a rural and metropolitan comparison.
    Tetstall E, Liu AJ, An EI, Canalese J, Nanan R.
    Aust N Z J Obstet Gynaecol; 2009 Jun 01; 49(3):279-84. PubMed ID: 19566560
    [Abstract] [Full Text] [Related]

  • 15. Pregnancy outcome in women who use opiates.
    Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T, Lindow SW.
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun 01; 126(2):170-5. PubMed ID: 16202501
    [Abstract] [Full Text] [Related]

  • 16. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
    Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H.
    Addiction; 2006 Feb 01; 101(2):275-81. PubMed ID: 16445556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Health service use and outcomes among disabled Medicaid pregnant women.
    Gavin NI, Benedict MB, Adams EK.
    Womens Health Issues; 2006 Feb 01; 16(6):313-22. PubMed ID: 17188214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.